FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma
Smaller Ultrasound-Guided Biopsy Needle Safe, Effective, For Suspected Breast Cancer
Gleevec First Pediatric Cancer Approval By FDA In 13 Years
FDA Clears Rapid Test For Aspergillus Infection
New Agent Targets Glioma Tumor Cells Prior To Surgery
Fruits, Vegetables Protective Against Cancer, IARC Says
Heavy Smokers And Drinkers Have Different Brain Chemistry
NCI-Approved Clinical Trials


Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - In the 90s, Barry Kramer persuaded NCI to get out of the business of screening guidelines
At the time, USPSTF was better equipped to do the job. Is it still?









